{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,17]],"date-time":"2026-05-17T06:21:45Z","timestamp":1778998905786,"version":"3.51.4"},"reference-count":43,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100007636","name":"Deutsche Bundesstiftung Umwelt","doi-asserted-by":"publisher","award":["AZ32725-31"],"award-info":[{"award-number":["AZ32725-31"]}],"id":[{"id":"10.13039\/100007636","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002347","name":"Bundesministerium f\u00fcr Bildung und Forschung","doi-asserted-by":"publisher","award":["16GW0057K"],"award-info":[{"award-number":["16GW0057K"]}],"id":[{"id":"10.13039\/501100002347","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmaceutics and Biopharmaceutics"],"published-print":{"date-parts":[[2019,1]]},"DOI":"10.1016\/j.ejpb.2018.11.012","type":"journal-article","created":{"date-parts":[[2018,11,16]],"date-time":"2018-11-16T04:27:45Z","timestamp":1542342465000},"page":"144-152","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"special_numbering":"C","title":["Predictive PBPK modeling as a tool in the formulation of the drug candidate TMP-001"],"prefix":"10.1016","volume":"134","author":[{"given":"Lisa","family":"Nothnagel","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fabian","family":"Jung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tanja","family":"Rossmanith","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manuela","family":"Thurn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mukul","family":"Ashtikar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gerd","family":"Geisslinger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael J.","family":"Parnham","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthias G.","family":"Wacker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejpb.2018.11.012_b0005","first-page":"175","article-title":"Multiple sclerosis review","volume":"37","author":"Goldenberg","year":"2012","journal-title":"Pharm. Therapeut."},{"key":"10.1016\/j.ejpb.2018.11.012_b0010","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1212\/WNL.33.11.1444","article-title":"Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS)","volume":"33","author":"Kurtzke","year":"1983","journal-title":"Neurology"},{"key":"10.1016\/j.ejpb.2018.11.012_b0015","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0132033","article-title":"Excess mortality in patients with multiple sclerosis starts at 20 years from clinical onset: Data from a large-scale French observational study","volume":"10","author":"Leray","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.ejpb.2018.11.012_b0020","first-page":"22","article-title":"Dysphagia and multiple sclerosis","volume":"11","author":"Prosiegel","year":"2004","journal-title":"Int. MS J."},{"key":"10.1016\/j.ejpb.2018.11.012_b0025","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1177\/1352458509358089","article-title":"Oropharyngeal dysphagia in multiple sclerosis","volume":"16","author":"Poorjavad","year":"2010","journal-title":"Multiple Sclerosis J."},{"key":"10.1016\/j.ejpb.2018.11.012_b0030","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1034\/j.1600-0404.2002.10062.x","article-title":"Dysphagia in multiple sclerosis \u2013 prevalence and prognostic factors","volume":"105","author":"Calcagno","year":"2002","journal-title":"Acta Neurologica Scandinavica"},{"key":"10.1016\/j.ejpb.2018.11.012_b0035","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/S0303-8467(02)00053-7","article-title":"Dysphagia in multiple sclerosis","volume":"104","author":"De Pauw","year":"2002","journal-title":"Clin. Neurol. Neurosurg."},{"key":"10.1016\/j.ejpb.2018.11.012_b0040","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1111\/j.1365-2982.2004.00541.x","article-title":"Oesophageal transport of solid dosage forms depends on body position, swallowing volume and pharyngeal propulsion velocity","volume":"16","author":"Osmanoglou","year":"2004","journal-title":"Neurogastroenterol. Motility"},{"key":"10.1016\/j.ejpb.2018.11.012_b0045","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1136\/gut.35.10.1363","article-title":"Impaired oesophageal transit of capsule versus tablet formulations in the elderly","volume":"35","author":"Perkins","year":"1994","journal-title":"Gut"},{"key":"10.1016\/j.ejpb.2018.11.012_b0050","unstructured":"International Conference for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH), Stability Testing of New Drug Substances and Products Q1A(R2), (2003)."},{"key":"10.1016\/j.ejpb.2018.11.012_b0055","unstructured":"International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH), Validation of Analytical Procedures: Test and Methodology Q2(R1), (2005)."},{"key":"10.1016\/j.ejpb.2018.11.012_b0060","unstructured":"International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH), Specifications: Test Procedures and Acceptance Criteria for New Drug Substances and New Drug Products: Chemical Substances (Q6A), (2000)."},{"key":"10.1016\/j.ejpb.2018.11.012_b0065","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1016\/j.ejpb.2018.03.010","article-title":"A comparison of two biorelevant in vitro drug release methods for nanotherapeutics based on advanced physiologically-based pharmacokinetic modelling","volume":"127","author":"Jung","year":"2018","journal-title":"Eur. J. Pharmaceut. Biopharmaceut."},{"key":"10.1016\/j.ejpb.2018.11.012_b0070","doi-asserted-by":"crossref","first-page":"3039","DOI":"10.1021\/mp500210c","article-title":"Quantification of gastrointestinal liquid volumes and distribution following a 240 mL dose of water in the fasted state","volume":"11","author":"Mudie","year":"2014","journal-title":"Mol. Pharmaceut."},{"key":"10.1016\/j.ejpb.2018.11.012_b0075","first-page":"152","article-title":"Reciprocal powered time model for release kinetic analysis of ibuprofen solid dispersions in oleaster powder, microcrystalline cellulose and crospovidone","volume":"13","author":"Mohammadi","year":"2010","journal-title":"J. Pharm. Pharmaceut. Sci."},{"key":"10.1016\/j.ejpb.2018.11.012_b0080","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1111\/j.1365-2036.2005.02683.x","article-title":"Intestinal fluid volumes and transit of dosage forms as assessed by magnetic resonance imaging","volume":"22","author":"Schiller","year":"2005","journal-title":"Alimentary Pharmacol. Therapeut."},{"key":"10.1016\/j.ejpb.2018.11.012_b0085","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1136\/gut.27.8.886","article-title":"Transit of pharmaceutical dosage forms through the small intestine","volume":"27","author":"Davis","year":"1986","journal-title":"Gut"},{"key":"10.1016\/j.ejpb.2018.11.012_b0090","unstructured":"T. Rossmanith, M.J. Parnham, Manuscript in Preparation, (2018 (Manuscript in preparation))."},{"key":"10.1016\/j.ejpb.2018.11.012_b0095","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1111\/j.2042-7158.2011.01429.x","article-title":"Comparison of in-vivo and in-silico methods used for prediction of tissue: plasma partition coefficients in rat","volume":"64","author":"Graham","year":"2012","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.ejpb.2018.11.012_b0100","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1007\/BF01061761","article-title":"The influence of variable gastric emptying and intestinal transit rates on the plasma level curve of cimetidine; an explanation for the double peak phenomenon","volume":"15","author":"Oberle","year":"1987","journal-title":"J. Pharmacokinet. Biopharmaceut."},{"key":"10.1016\/j.ejpb.2018.11.012_b0105","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1111\/j.1572-0241.1999.00862.x","article-title":"Gastrointestinal sounds and migrating motor complex in fasted humans","volume":"94","author":"Tomomasa","year":"1999","journal-title":"Am. J. Gastroenterol."},{"key":"10.1016\/j.ejpb.2018.11.012_b0110","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1007\/s00455-011-9379-4","article-title":"Gender Effect on Oral Volume Capacity","volume":"27","author":"Nascimento","year":"2012","journal-title":"Dysphagia"},{"key":"10.1016\/j.ejpb.2018.11.012_b0115","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/BF00385799","article-title":"Normal adult swallowing of liquid and viscous material: scintigraphic data on bolus transit and oropharyngeal residues","volume":"11","author":"Hamlet","year":"1996","journal-title":"Dysphagia"},{"key":"10.1016\/j.ejpb.2018.11.012_b0120","series-title":"Studies in chemical dynamics","author":"Hoff","year":"1896"},{"key":"10.1016\/j.ejpb.2018.11.012_b0125","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/prp2.131","article-title":"Incorporation of concentration data below the limit of quantification in population pharmacokinetic analyses","volume":"3","author":"Keizer","year":"2015","journal-title":"Pharmacol. Res. Perspect."},{"key":"10.1016\/j.ejpb.2018.11.012_b0130","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/j.ejps.2013.08.024","article-title":"In vitro models for the prediction of in vivo performance of oral dosage forms","volume":"57","author":"Kostewicz","year":"2014","journal-title":"Eur. J. Pharmaceut. Sci."},{"key":"10.1016\/j.ejpb.2018.11.012_b0135","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1023\/A:1015800932454","article-title":"Absorption of flurbiprofen in the fed and fasted states","volume":"9","author":"Dressman","year":"1992","journal-title":"Pharmaceut. Res."},{"key":"10.1016\/j.ejpb.2018.11.012_b0140","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1111\/j.1365-2125.2008.03289.x","article-title":"Population pharmacokinetics of oral diclofenac for acute pain in children","volume":"66","author":"Standing","year":"2008","journal-title":"British J. Clin. Pharmacol."},{"key":"10.1016\/j.ejpb.2018.11.012_b0145","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.3748\/wjg.v13.i9.1365","article-title":"Mechanics of flow and mixing at antroduodenal junction","volume":"13","author":"Dillard","year":"2007","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.ejpb.2018.11.012_b0150","series-title":"Quantitative Human Physiology","first-page":"711","article-title":"8.3 - Intestinal and Colonic Motility","author":"Feher","year":"2012"},{"key":"10.1016\/j.ejpb.2018.11.012_b0155","series-title":"Physiology of the Gastrointestinal Tract (Fifth Edition)","first-page":"951","article-title":"Chapter 34 - Neurophysiologic Mechanisms of Gastric Reservoir Function A2 - Johnson, Leonard R","author":"Tack","year":"2012"},{"key":"10.1016\/j.ejpb.2018.11.012_b0160","series-title":"Developing Solid Oral Dosage Forms (Second Edition)","first-page":"331","article-title":"Chapter 12 - Oral Drug Absorption: Evaluation and Prediction","author":"Yang","year":"2017"},{"key":"10.1016\/j.ejpb.2018.11.012_b0165","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1016\/S0016-5085(82)80145-5","article-title":"Analysis of gastric emptying data","volume":"83","author":"Elashoff","year":"1982","journal-title":"Gastroenterology"},{"key":"10.1016\/j.ejpb.2018.11.012_b0170","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1007\/s11095-009-9869-3","article-title":"Gastric emptying of pellets under fasting conditions: A mathematical model","volume":"26","author":"Locatelli","year":"2009","journal-title":"Pharmaceut. Res."},{"key":"10.1016\/j.ejpb.2018.11.012_b0175","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0153297","article-title":"Realistic stochastic model of gastric emptying","volume":"11","author":"Yokrattanasak","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.ejpb.2018.11.012_b0180","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.ejpb.2008.02.022","article-title":"Mechanistic understanding of time-dependent oral absorption based on gastric motor activity in humans","volume":"70","author":"Higaki","year":"2008","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ejpb.2018.11.012_b0185","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0156443","article-title":"A mechanistic model of intermittent gastric emptying and glucose-insulin dynamics following a meal containing milk components","volume":"11","author":"Stahel","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.ejpb.2018.11.012_b0190","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1002\/bdd.1937","article-title":"Does age affect gastric emptying time? A model-based meta-analysis of data from premature neonates through to adults","volume":"36","author":"Bonner","year":"2015","journal-title":"Biopharm. Drug Dispos."},{"key":"10.1016\/j.ejpb.2018.11.012_b0195","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1208\/s12248-012-9324-y","article-title":"A mechanism-based approach for absorption modeling: The Gastro-Intestinal Transit Time (GITT) Model","volume":"14","author":"H\u00e9nin","year":"2012","journal-title":"Aaps J."},{"key":"10.1016\/j.ejpb.2018.11.012_b0200","series-title":"Developing Solid Oral Dosage Forms (second ed.)","first-page":"399","article-title":"Chapter 15 - Predictive Biopharmaceutics and Pharmacokinetics: Modeling and Simulation**The opinions expressed in this report by the authors do not reflect the views or policies of the Food and Drug Administration (FDA)","author":"Yang","year":"2017"},{"key":"10.1016\/j.ejpb.2018.11.012_b0205","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1208\/s12248-009-9099-y","article-title":"Population-based mechanistic prediction of oral drug absorption","volume":"11","author":"Jamei","year":"2009","journal-title":"Aaps J."},{"key":"10.1016\/j.ejpb.2018.11.012_b0210","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/0016-5085(78)90762-X","article-title":"Bioavailability of cimetidine in man","volume":"74","author":"Walkenstein","year":"1978","journal-title":"Gastroenterology"},{"key":"10.1016\/j.ejpb.2018.11.012_b0215","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1002\/bdd.2510050210","article-title":"Comparative bioavailability study of two tablet formulations of cimetidine","volume":"5","author":"Berardi","year":"1984","journal-title":"Biopharmaceut. Drug Disposition"}],"container-title":["European Journal of Pharmaceutics and Biopharmaceutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939641118308543?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939641118308543?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T16:31:46Z","timestamp":1760545906000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0939641118308543"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1]]},"references-count":43,"alternative-id":["S0939641118308543"],"URL":"https:\/\/doi.org\/10.1016\/j.ejpb.2018.11.012","relation":{},"ISSN":["0939-6411"],"issn-type":[{"value":"0939-6411","type":"print"}],"subject":[],"published":{"date-parts":[[2019,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Predictive PBPK modeling as a tool in the formulation of the drug candidate TMP-001","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmaceutics and Biopharmaceutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejpb.2018.11.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}